{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:44:49Z","timestamp":1777877089161,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,30]]},"DOI":"10.7759\/cureus.108052","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:41:07Z","timestamp":1777588867000},"source":"Crossref","is-referenced-by-count":0,"title":["Osteogenesis Imperfecta Type 4 With COL1A2 c.1135G>A (p.Gly379Arg) Variant: Unmodified by Concurrent ALPL c.1559delT (p.Leu520ArgfsTer86) Carrier Status: A Case Report"],"prefix":"10.7759","author":[{"given":"Kento","family":"Nomura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichiro","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Namai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000626","article-title":"Hypophosphatasia: from birth to adulthood","volume":"67","author":"Reis FS","year":"2023","unstructured":"Reis FS, Lazaretti-Castro M. Hypophosphatasia: from birth to adulthood. Arch Endocrinol Metab. 2023, 67:e000626. 10.20945\/2359-3997000000626","journal-title":"Arch Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.2056","article-title":"Not just a carrier: clinical presentation and management of patients with heterozygous disease-causing alkaline phosphatase (ALPL) variants identified through expanded carrier screening","volume":"11","author":"Beck NM","year":"2023","unstructured":"Beck NM, Sagaser KG, Lawson CS, et al.. Not just a carrier: clinical presentation and management of patients with heterozygous disease-causing alkaline phosphatase (ALPL) variants identified through expanded carrier screening. Mol Genet Genomic Med. 2023, 11:e2056. 10.1002\/mgg3.2056","journal-title":"Mol Genet Genomic Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01798-1","article-title":"Clinical and genetic characteristics of hypophosphatasia in Chinese children","volume":"16","author":"Liu M","year":"2021","unstructured":"Liu M, Liu M, Liang X, et al.. Clinical and genetic characteristics of hypophosphatasia in Chinese children. Orphanet J Rare Dis. 2021, 16:159. 10.1186\/s13023-021-01798-1","journal-title":"Orphanet J Rare Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1297\/cpe.2025-0009","article-title":"Osteogenesis imperfecta: pathogenesis, classification, and treatment","volume":"34","author":"Hasegawa K","year":"2025","unstructured":"Hasegawa K. Osteogenesis imperfecta: pathogenesis, classification, and treatment. Clin Pediatr Endocrinol. 2025, 34:152-61. 10.1297\/cpe.2025-0009","journal-title":"Clin Pediatr Endocrinol"},{"key":"ref5","article-title":"Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2","volume":"46","author":"Sykes B","year":"1990","unstructured":"Sykes B, Ogilvie D, Wordsworth P, et al.. Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2. Am J Hum Genet. 1990, 46:293-307.","journal-title":"Am J Hum Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63132","article-title":"Nosology of genetic skeletal disorders: 2023 revision","volume":"191","author":"Unger S","year":"2023","unstructured":"Unger S, Ferreira CR, Mortier GR, et al.. Nosology of genetic skeletal disorders: 2023 revision. Am J Med Genet A. 2023, 191:1164-209. 10.1002\/ajmg.a.63132","journal-title":"Am J Med Genet A"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2010.161","article-title":"Prevalence of c.1559delT in ALPL, a common mutation resulting in the perinatal (lethal) form of hypophosphatasia in Japanese and effects of the mutation on heterozygous carriers","volume":"56","author":"Watanabe A","year":"2011","unstructured":"Watanabe A, Karasugi T, Sawai H, Naing BT, Ikegawa S, Orimo H, Shimada T. Prevalence of c.1559delT in ALPL, a common mutation resulting in the perinatal (lethal) form of hypophosphatasia in Japanese and effects of the mutation on heterozygous carriers. J Hum Genet. 2011, 56:166-8. 10.1038\/jhg.2010.161","journal-title":"J Hum Genet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-019-0712-3","article-title":"Association of ALPL variants with serum alkaline phosphatase and bone traits in the general Japanese population: the Nagahama study","volume":"65","author":"Nagata M","year":"2020","unstructured":"Nagata M, Setoh K, Takahashi M, et al.. Association of ALPL variants with serum alkaline phosphatase and bone traits in the general Japanese population: the Nagahama study. J Hum Genet. 2020, 65:337-43. 10.1038\/s10038-019-0712-3","journal-title":"J Hum Genet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-019-00626-w","article-title":"Hypophosphatasia in Japan: ALPL mutation analysis in 98 unrelated patients","volume":"106","author":"Michigami T","year":"2020","unstructured":"Michigami T, Tachikawa K, Yamazaki M, Kawai M, Kubota T, Ozono K. Hypophosphatasia in Japan: ALPL mutation analysis in 98 unrelated patients. Calcif Tissue Int. 2020, 106:221-31. 10.1007\/s00223-019-00626-w","journal-title":"Calcif Tissue Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2012-0266","article-title":"Phosphoethanolamine normal range in pediatric urines for hypophosphatasia screening","volume":"50","author":"Imbard A","year":"2012","unstructured":"Imbard A, Alberti C, Armoogum-Boizeau P, Ottolenghi C, Josserand E, Rigal O, Benoist JF. Phosphoethanolamine normal range in pediatric urines for hypophosphatasia screening. Clin Chem Lab Med. 2012, 50:2231-3. 10.1515\/cclm-2012-0266","journal-title":"Clin Chem Lab Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-016-3709-1","article-title":"DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum","volume":"27","author":"Bardai G","year":"2016","unstructured":"Bardai G, Moffatt P, Glorieux FH, Rauch F. DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum. Osteoporos Int. 2016, 27:3607-13. 10.1007\/s00198-016-3709-1","journal-title":"Osteoporos Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2023.116683","article-title":"Genetic analysis of osteogenesis imperfecta in a large Brazilian cohort","volume":"169","author":"Holtz AP","year":"2023","unstructured":"Holtz AP, Souza LT, Ribeiro EM, et al.. Genetic analysis of osteogenesis imperfecta in a large Brazilian cohort. Bone. 2023, 169:116683. 10.1016\/j.bone.2023.116683","journal-title":"Bone"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1149982","article-title":"NGS analysis of collagen type I genes in Polish patients with osteogenesis imperfecta: a nationwide multicenter study","volume":"14","author":"Sa\u0142aci\u0144ska K","year":"2023","unstructured":"Sa\u0142aci\u0144ska K, Pinkier I, Rutkowska L, et al.. NGS analysis of collagen type I genes in Polish patients with osteogenesis imperfecta: a nationwide multicenter study. Front Endocrinol (Lausanne). 2023, 14:1149982. 10.3389\/fendo.2023.1149982","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127254","article-title":"Correction: development of a high-throughput resequencing array for the detection of pathogenic mutations in osteogenesis imperfecta","volume":"10","author":"Wang Y","year":"2015","unstructured":"Wang Y, Cui Y, Zhou X, Han J. Correction: development of a high-throughput resequencing array for the detection of pathogenic mutations in osteogenesis imperfecta. PLoS One. 2015, 10:e0127254. 10.1371\/journal.pone.0127254","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2023.104856","article-title":"Combination of osteogenesis imperfecta and hypophosphatasia in three children with multiple fractures, low bone mass and severe osteomalacia, a challenge for therapeutic management","volume":"66","author":"Fratzl-Zelman N","year":"2023","unstructured":"Fratzl-Zelman N, Linglart A, Bin K, Rauch F, Blouin S, Coutant R, Donzeau A. Combination of osteogenesis imperfecta and hypophosphatasia in three children with multiple fractures, low bone mass and severe osteomalacia, a challenge for therapeutic management. Eur J Med Genet. 2023, 66:104856. 10.1016\/j.ejmg.2023.104856","journal-title":"Eur J Med Genet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.57582\/IJBF.250501.029","article-title":"Weaving bone resilience: a case of co-occurrence of osteogenesis imperfecta and hypophosphatasia","volume":"5","author":"Rodrigues JR","year":"2025","unstructured":"Rodrigues JR, Machado R, Travessa AM, et al.. Weaving bone resilience: a case of co-occurrence of osteogenesis imperfecta and hypophosphatasia. Int J Bone Frag. 2025, 5:29-32. 10.57582\/IJBF.250501.029","journal-title":"Int J Bone Frag"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2005.04597.x","article-title":"Novel aggregate formation of a frame-shift mutant protein of tissue-nonspecific alkaline phosphatase is ascribed to three cysteine residues in the C-terminal extension. Retarded secretion and proteasomal degradation","volume":"272","author":"Komaru K","year":"2005","unstructured":"Komaru K, Ishida Y, Amaya Y, Goseki-Sone M, Orimo H, Oda K. Novel aggregate formation of a frame-shift mutant protein of tissue-nonspecific alkaline phosphatase is ascribed to three cysteine residues in the C-terminal extension. Retarded secretion and proteasomal degradation. FEBS J. 2005, 272:1704-17. 10.1111\/j.1742-4658.2005.04597.x","journal-title":"FEBS J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2013.139","article-title":"Relationship between serum 25-hydroxyvitamin D and parathyroid hormone in the search for a biochemical definition of vitamin D deficiency in children","volume":"74","author":"Atapattu N","year":"2013","unstructured":"Atapattu N, Shaw N, H\u00f6gler W. Relationship between serum 25-hydroxyvitamin D and parathyroid hormone in the search for a biochemical definition of vitamin D deficiency in children. Pediatr Res. 2013, 74:552-6. 10.1038\/pr.2013.139","journal-title":"Pediatr Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/485652-osteogenesis-imperfecta-type-4-with-col1a2-c1135ga-pgly379arg-variant-unmodified-by-concurrent-alpl-c1559delt-pleu520argfster86-carrier-status-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:41:08Z","timestamp":1777588868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/485652-osteogenesis-imperfecta-type-4-with-col1a2-c1135ga-pgly379arg-variant-unmodified-by-concurrent-alpl-c1559delt-pleu520argfster86-carrier-status-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.108052","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,30]]}}}